Tcr Gene Transduction
Tcr Gene Transduction - Related Videos
04:59
Retroviral-Mediated Transduction: A Method to Introduce Target Gene into Cancer Cells
0 Views •
2023
This video describes the protocol for genetic validation by transferring target genes using retroviruses in chronic myeloid leukemia cell lines. The retroviruses act as a mediator to transfer genetic material into the leukemia cell through the process called transduction, which enables long term expression of target gene.This method can be applied to any target cells for genetic validation and therapeutic development.
10:14
Retroviral Transduction of T-cell Receptors in Mouse T-cells
0 Views •
Cited by 21 •
2010
We present a protocol to produce antigen-specific mouse T-cells using retroviral...
19:05
Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay
0 Views •
Cited by 8 •
2015
This manuscript describes how to conduct (single molecule) Förster Resonance Energy Transfer (FRET)- based assays to measure the binding dynamics between T-cell antigen receptor (TCR) and antigenic peptide-loaded MHC molecules as they occur within the immunological synapse of a T-cell in contact with a functionalized planar supported lipid bilayer.
08:45
Evaluation of 3D Spheroids for AAV Transduction Studies
0 Views •
2026
Three-dimensional spheroid culture systems improve upon conventional 2D models for AAV gene therapy development. This methodology enables sensitive detection of AAV transduction at low doses, enhanced physiological relevance, and robust long-term monitoring. The platform supports potency assessment, high-throughput screening, and vector optimization across diverse cell lines and AAV serotypes.
08:48
Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain
0 Views •
Cited by 3 •
2016
Herein we describe a novel method to generate antigen-specific T cell receptors (TCRs) by pairing the TCRα or TCRβ of an existing TCR, possessing the antigen-specificity of interest, with complementary hemichain of the peripheral T cell receptor repertoire. The de novo generated TCRs retain antigen-specificity with varying affinity.
FAQs
The introduced receptor is formed from genes encoding TCR alpha and beta chains, allowing engineered T cells to display a defined receptor rather than relying only on their original specificity. This receptor guides recognition of selected antigenic targets and provides the molecular basis for examining how T cells respond to particular pathogen-derived peptides.
TCR gene transduction typically supplies genes for both receptor chains because the engineered receptor is defined by their combined expression. Evaluating the resulting T cells therefore requires more than confirming genetic delivery alone. Researchers examine receptor expression and then determine whether the paired chains support antigen binding and functional activation.
Recognition is studied in the context of pathogen-derived peptides presented by major histocompatibility complex molecules. Consequently, antigen specificity is not assessed as peptide binding in isolation; it is examined through the interaction between the engineered TCR and the presented target. This framework helps clarify how T cells identify infection-related antigens.
These measurements address different stages of receptor performance. Receptor-expression testing indicates whether the introduced TCR is present, antigen-binding assays examine target recognition, and functional-activation tests show whether that recognition produces a cellular response. Considering all three provides a more complete assessment than using expression alone to judge successful engineering.
A typical workflow begins with isolated T lymphocytes and delivery of genes encoding the selected TCR alpha and beta chains through a viral vector. The modified cells are then expanded before researchers test receptor expression, antigen binding, and functional activation. This sequence connects genetic introduction with measurable cellular behavior.
Expansion increases the available population of modified T lymphocytes for subsequent analysis. After this stage, researchers can evaluate whether the cells express the introduced receptor, bind the intended antigen, and become functionally activated. Linking expansion to these measurements supports systematic characterization of the engineered cell product in experimental studies.
The approach provides a controlled way to investigate T-cell specificity and signaling during recognition of pathogen-derived peptides presented by major histocompatibility complex molecules. By giving lymphocytes a defined receptor and then assessing binding and activation, researchers can examine how receptor specificity relates to immune responses against infection-associated targets.
TCR gene transduction supports adoptive cell therapy development by supplying T lymphocytes with a selected antigen-specific receptor before the cells are expanded and evaluated. Expression, antigen binding, and functional activation measurements help characterize whether the engineered cells display the intended properties, providing experimental information relevant to targeted immune-cell approaches.